Our Pricing

Your Mounjaro Dose Increase Questions Answered

Published on: June 03, 2026

Understanding when to increase mounjaro dose uk is essential for safe, effective weight management under prescriber supervision. At Cured Pharmacy, our UK-registered clinical team guides patients through evidence-based titration schedules, helping you navigate dose escalation whilst minimising side effects and maximising clinical outcomes with genuine UK-licensed Mounjaro from £124.99.

The Standard Mounjaro Dose Escalation Schedule

Mounjaro follows a structured titration protocol designed to optimise tolerability whilst building therapeutic efficacy. The MHRA-approved schedule begins at 2.5mg once weekly for four weeks, serving as an initiation dose rather than a therapeutic maintenance level [1]. This gradual approach allows your body to adapt to tirzepatide's dual GIP/GLP-1 receptor activation, significantly reducing gastrointestinal side effects compared to rapid escalation.

After the initial four-week period, your UK prescriber will typically increase your dose to 5mg weekly, where most patients remain for at least another four weeks before considering further escalation [1]. The standard progression continues to 7.5mg, 10mg, 12.5mg, and finally 15mg — each increment separated by a minimum four-week interval to assess response and tolerability.

Clinical data from the SURPASS trials demonstrated that this methodical titration schedule resulted in 89% of participants completing the full dose escalation protocol, compared to significantly higher discontinuation rates with faster titration [2]. Your individual progression through these doses depends entirely on your response, side effect profile, and prescriber assessment at each stage.

When Your Prescriber Will Recommend Dose Increases

Your UK prescriber evaluates several clinical factors before approving each Mounjaro dose increase. Weight loss velocity is a primary consideration — if you've achieved less than 5% body weight reduction after 12 weeks on your current maintenance dose, escalation may be clinically appropriate [1]. Equally important is side effect tolerability: persistent nausea, vomiting, or gastrointestinal disturbance at your current dose typically indicates you should remain at that level longer.

Prescribers also assess glycaemic control in patients with type 2 diabetes, adherence to lifestyle modifications, and individual treatment goals. The SURPASS-3 trial showed that patients who reached higher maintenance doses (12.5mg or 15mg) achieved average weight reductions of 22.5% over 72 weeks, compared to 15.7% for those maintained on lower doses [2]. However, clinical benefit must always be balanced against tolerability and individual response.

Never increase your Mounjaro dose without explicit prescriber approval. Self-directed escalation increases the risk of severe gastrointestinal side effects, dehydration, and treatment discontinuation. At Cured Pharmacy, our clinical team conducts regular follow-up assessments to determine optimal timing for your dose progression, ensuring safe and effective treatment under continuous medical supervision.

Signs You're Ready for Dose Escalation

Your prescriber may consider dose escalation if you've completed at least four weeks on your current dose with minimal side effects, your weight loss has plateaued despite adherence to diet and exercise modifications, and you have no contraindications such as persistent nausea or pancreatitis symptoms. Clinical assessment remains essential — these indicators inform but never replace prescriber judgement regarding appropriate timing for your individual circumstances.

Managing Side Effects During Dose Increases

Gastrointestinal side effects intensify temporarily with each Mounjaro dose increase, typically peaking within the first week of escalation before gradually subsiding [1]. Nausea affects approximately 25-30% of patients during titration, whilst diarrhoea, constipation, and reduced appetite occur in 15-20% of cases [2]. These effects result from tirzepatide's mechanism of action — slowed gastric emptying and enhanced satiety signalling — rather than toxicity.

Practical management strategies significantly improve tolerability during dose escalation. Eat smaller, more frequent meals rather than three large portions, as reduced gastric capacity makes large meals uncomfortable. Avoid high-fat, spicy, or heavily processed foods during the first 7-10 days after each increase, as these exacerbate nausea. Stay well-hydrated with small, frequent sips throughout the day, particularly if experiencing vomiting or diarrhoea, to prevent dehydration.

If side effects remain severe beyond two weeks at your new dose, contact your prescriber immediately rather than persisting through discomfort. Your clinical team may recommend remaining at your current dose longer, implementing additional dietary modifications, or in some cases, temporarily reducing your dose before attempting escalation again. The SURPASS trials demonstrated that flexible, patient-centred titration approaches resulted in better long-term adherence than rigid protocols [2].

When to Contact Your Prescriber Urgently

Seek immediate medical advice if you experience severe abdominal pain that doesn't resolve, persistent vomiting preventing fluid intake, signs of pancreatitis (severe upper abdominal pain radiating to your back), visual changes, or symptoms of thyroid tumours (lump in neck, difficulty swallowing). Whilst rare, these symptoms require urgent clinical assessment and may necessitate treatment discontinuation rather than dose escalation.

How Long to Stay on Each Mounjaro Dose

The minimum recommended duration at each Mounjaro dose is four weeks, allowing sufficient time for therapeutic adaptation and clinical assessment [1]. However, many patients benefit from extended periods at intermediate doses before escalating further. Clinical data suggests that 40% of patients achieve their target weight loss on doses of 7.5mg or 10mg weekly, never requiring escalation to the maximum 15mg dose [2].

Your prescriber determines optimal duration at each dose level based on weight loss trajectory, side effect profile, and individual treatment goals. If you're experiencing consistent weight loss of 1-2% body weight per month with minimal side effects, your clinical team may recommend remaining at your current dose rather than escalating. Conversely, if weight loss stalls after 8-12 weeks despite lifestyle adherence, dose escalation becomes clinically appropriate.

Some patients remain on their maintenance dose indefinitely once achieving target weight loss, using Mounjaro for weight maintenance rather than continued reduction. The SURMOUNT-4 trial demonstrated that patients who continued tirzepatide after reaching their goal weight maintained 94% of their weight loss over 52 weeks, compared to significant regain in those who discontinued [3]. Your long-term dosing strategy should be individualised through ongoing prescriber consultation.

Mounjaro Dose Increases vs Other Weight Loss Treatments

Mounjaro's titration schedule differs significantly from other injectable weight loss treatments available in the UK. Wegovy (semaglutide) follows a similar escalation protocol but typically requires five dose increases over 16-20 weeks to reach the 2.4mg maintenance dose, compared to Mounjaro's potential six-step escalation over 24 weeks to 15mg [1][4]. This extended titration reflects tirzepatide's dual receptor mechanism and higher potency.

Saxenda (liraglutide) requires daily injections with weekly dose increases over five weeks, reaching the 3mg maintenance dose faster than either Mounjaro or Wegovy. However, clinical trials demonstrate that Mounjaro produces superior average weight loss outcomes — 22.5% body weight reduction at maximum dose versus 15.8% for Wegovy and 8.4% for Saxenda over comparable timeframes [2][4][5].

The choice between these treatments depends on individual factors including injection frequency preference, side effect tolerance, previous treatment response, and clinical suitability. At Cured Pharmacy, our UK prescribers assess your complete medical history to recommend the most appropriate weight loss treatment and titration schedule for your circumstances, with transparent pricing and ongoing clinical support throughout your treatment journey.

Switching Between Weight Loss Treatments

If you're currently using Wegovy or Saxenda and considering switching to Mounjaro, your prescriber will determine appropriate starting dose based on your current treatment and response. Direct dose equivalence doesn't exist between these medications due to different mechanisms and potencies. Most patients switching from Wegovy begin Mounjaro at 2.5mg with standard escalation, whilst those discontinuing Saxenda may start at 2.5mg or 5mg depending on tolerability and clinical assessment.

Getting Your Mounjaro Dose Increase Through Cured Pharmacy

Cured Pharmacy simplifies the Mounjaro dose escalation process through our UK-registered clinical team and streamlined prescription service. When you're ready for your next dose increase, complete a brief follow-up consultation detailing your weight loss progress, side effects, and treatment experience. Our prescribers review your submission within 24 hours, issuing your new prescription if clinically appropriate.

Your escalated dose is dispensed from our UK-registered pharmacy with discreet next-day delivery, ensuring seamless transition between dose levels without treatment gaps. We maintain complete treatment records, tracking your progression through the titration schedule and flagging any clinical concerns requiring additional prescriber review. This continuity of care optimises safety and efficacy throughout your weight loss journey.

Transparent pricing remains consistent across all Mounjaro doses at Cured Pharmacy, with genuine UK-licensed medication from £124.99. Unlike some providers who increase costs with higher doses, our pricing structure ensures predictable treatment expenses as you progress through escalation. All patients receive the same high-quality clinical assessment, genuine medication, and discreet delivery regardless of dose level, supported by our superintendent pharmacist Tarun Kumar (GPhC 2233073) and UK-registered clinical team.

Scientific References

1. Electronic Medicines Compendium. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen - Summary of Product Characteristics. https://www.medicines.org.uk/emc/product/14298 [accessed 13 August 2026]
2. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
3. Aronne, L. J., Sattar, N., Horn, D. B., et al. (2024). Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical Trial. JAMA, 331(1), 38–48. https://doi.org/10.1001/jama.2023.24945 [accessed 13 August 2026]
4. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
5. Pi-Sunyer, X., Astrup, A., Fujioka, K., et al. (2015). A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. New England Journal of Medicine, 373(1), 11–22. https://doi.org/10.1056/NEJMoa1411892 [accessed 13 August 2026]
6. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
7. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
8. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Mounjaro dose escalation must only occur under direct prescriber supervision following individual clinical review. Never adjust your dose without explicit medical approval. Always consult a qualified healthcare professional before starting any new medication or changing your treatment regimen.